ENB Therapeutics has filed a notice of an exempt offering of securities to raise $1,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, ENB Therapeutics is raising $1,000,000.00 in new funding. Sources indicate that as part of senior management President, Sumayah Jamal played a key role in securing…